Danièle Lantoine

1000 total citations
15 papers, 839 citations indexed

About

Danièle Lantoine is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Danièle Lantoine has authored 15 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Oncology. Recurrent topics in Danièle Lantoine's work include Cancer-related gene regulation (5 papers), Acute Myeloid Leukemia Research (4 papers) and RNA Research and Splicing (4 papers). Danièle Lantoine is often cited by papers focused on Cancer-related gene regulation (5 papers), Acute Myeloid Leukemia Research (4 papers) and RNA Research and Splicing (4 papers). Danièle Lantoine collaborates with scholars based in France, United States and United Kingdom. Danièle Lantoine's co-authors include Sabine Quief, Olivier Albagli, Philippe Dhordain, Jean‐Pierre Kerckaert, Clotilde Deweindt, Richard J. Lin, Ronald M. Evans, Dominique Leprince, Sylvie Galiègue‐Zouitina and Marcel Koken and has published in prestigious journals such as Nucleic Acids Research, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Danièle Lantoine

15 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danièle Lantoine France 12 546 198 187 158 109 15 839
J. Thick United Kingdom 8 486 0.9× 129 0.7× 257 1.4× 122 0.8× 115 1.1× 9 688
Hélène Dastot France 14 328 0.6× 302 1.5× 191 1.0× 129 0.8× 161 1.5× 26 789
Tetsuharu Shinjyo Japan 10 453 0.8× 157 0.8× 181 1.0× 51 0.3× 68 0.6× 13 703
K Toyoshima Japan 11 510 0.9× 329 1.7× 282 1.5× 60 0.4× 62 0.6× 13 1.0k
Alan Sawyer Italy 8 626 1.1× 246 1.2× 92 0.5× 61 0.4× 254 2.3× 10 960
H.L. Drwinga United States 6 340 0.6× 83 0.4× 141 0.8× 111 0.7× 86 0.8× 10 598
Kwok Peng Ng United States 14 552 1.0× 106 0.5× 112 0.6× 50 0.3× 76 0.7× 20 741
Kelly Morgan United States 13 1.1k 1.9× 202 1.0× 179 1.0× 45 0.3× 172 1.6× 25 1.3k
Anatoliy Koval United States 7 501 0.9× 420 2.1× 168 0.9× 193 1.2× 418 3.8× 8 999
Cihan Cetinkaya Sweden 9 860 1.6× 88 0.4× 423 2.3× 87 0.6× 69 0.6× 10 1.0k

Countries citing papers authored by Danièle Lantoine

Since Specialization
Citations

This map shows the geographic impact of Danièle Lantoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danièle Lantoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danièle Lantoine more than expected).

Fields of papers citing papers by Danièle Lantoine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danièle Lantoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danièle Lantoine. The network helps show where Danièle Lantoine may publish in the future.

Co-authorship network of co-authors of Danièle Lantoine

This figure shows the co-authorship network connecting the top 25 collaborators of Danièle Lantoine. A scholar is included among the top collaborators of Danièle Lantoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danièle Lantoine. Danièle Lantoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Preudhomme, Claude, Christophe Roumier, Marie‐Paule Hildebrand, et al.. (2000). Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene. 19(16). 2023–2032. 96 indexed citations
3.
Albagli, Olivier, Catherine Lindon, Danièle Lantoine, et al.. (2000). DNA Replication Progresses on the Periphery of Nuclear Aggregates Formed by the BCL6 Transcription Factor. Molecular and Cellular Biology. 20(22). 8560–8570. 15 indexed citations
4.
Dhordain, Philippe, Olivier Albagli, Nicole Honoré, et al.. (2000). Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene. 19(54). 6240–6250. 66 indexed citations
5.
Albagli, Olivier, Danièle Lantoine, Sabine Quief, et al.. (1999). Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci. Oncogene. 18(36). 5063–5075. 59 indexed citations
6.
Dhordain, Philippe, Sabine Quief, Danièle Lantoine, et al.. (1998). The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Research. 26(20). 4645–4651. 202 indexed citations
7.
Albagli, Olivier, Philippe Dhordain, Danièle Lantoine, et al.. (1998). Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis. Differentiation. 64(1). 33–44. 21 indexed citations
8.
Dhordain, Philippe, Olivier Albagli, Stéphane Ansieau, et al.. (1995). The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.. PubMed. 11(12). 2689–97. 102 indexed citations
9.
Mestdagh, Nathalie, et al.. (1995). EXPRESSION OF A TUMOR-SUPPRESSOR GENE AND OF VARIOUS PROTOONCOGENES IN HUMAN AND MURINE ADRIAMYCIN-RESISTANT AND SENSITIVE CELL-LINES. International Journal of Oncology. 6(6). 1255–60. 1 indexed citations
10.
Galiègue‐Zouitina, Sylvie, M Collyn-d'Hooghe, Sabine Quief, et al.. (1995). TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation.. PubMed. 10(11). 2171–8. 102 indexed citations
11.
Deweindt, Clotilde, Olivier Albagli, Florent Bernardin, et al.. (1995). The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.. PubMed. 6(12). 1495–503. 130 indexed citations
12.
Galiègue‐Zouitina, Sylvie, et al.. (1993). Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies.. PubMed. 7(11). 1777–85. 12 indexed citations
13.
Bailly, Christian, M Collyn-d'Hooghe, Danièle Lantoine, et al.. (1992). Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase ii. Biochemical Pharmacology. 43(3). 457–466. 14 indexed citations
14.
Collyn-d'Hooghe, M, B. Vandewalle, Louis Hornez, et al.. (1992). C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.. PubMed. 11(6). 2175–9. 3 indexed citations
15.
Fenaux, Pierre, et al.. (1990). Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.. PubMed. 32(3). 175–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026